Table 1 The characteristics of patients in each treatment arms
| Â | ECF group1 | TCF group2 | P4 | ||
|---|---|---|---|---|---|
| Â | All (n = 42) No. (%) | QOL3 (n = 35) No. (%) | All (n = 44) No. (%) | QOL3 (n = 36) No. (%) | Â |
Age | Â | Â | Â | Â | 0.23 |
Mean (SD) | 57. 2 (9.83) | 58.1 (10.48) | 55.4 (14.04) | 54.2 (16.18) | Â |
Gender | Â | Â | Â | Â | 0.20 |
Male | 34 (81) | 28 (80) | 31 (70) | 24 (67) | Â |
Female | 8 (19) | 7 (20) | 13 (30) | 12 (33) | Â |
Tumor size | Â | Â | Â | Â | 0.48 |
T2 | 8 (19) | 8 (23) | 5 (11) | 5 (14) | Â |
T3 | 15 (36) | 12 (34) | 15 (34) | 11 (31) | Â |
T4 | 19 (45) | 15 (43) | 24 (55) | 20 (55) | Â |
Lymph node | Â | Â | Â | Â | 0.39 |
L1 | 20 (48) | 18 (51) | 14 (32) | 14 (39) | Â |
L2 | 17 (40) | 13 (37) | 20 (45) | 14 (39) | Â |
Not involvement | 5 (12) | 4 (12) | 10 (23) | 8 (22) | Â |
Differentiation | Â | Â | Â | Â | 0.30 |
Well differentiated | 7 (17) | 7 (20) | 5 (11) | 4 (11) | Â |
Others | 35 (83) | 28 (80) | 39 (89) | 32 (89) | Â |
Tumor of cardia | Â | Â | Â | Â | 0.56 |
Yes | 19 (45) | 14 (40) | 15 (34) | 12 (33) | Â |
Others | 23 (55) | 21 (60) | 29 (66) | 24 (67) | Â |
Metastatic site | Â | Â | Â | Â | 0.92 |
Liver | 7 (17) | 7 (20) | 9 (20) | 7 (20) | Â |
Peritoneum | 13 (31) | 10 (29) | 14 (32) | 9 (25) | Â |
Para aortic | 5 (12) | 4 (11) | 3 (7) | 3 (8) | Â |
Multiple sites | 17 (40) | 14 (40) | 18 (41) | 17 (47) | Â |
Primary disease | Â | Â | Â | Â | 0.93 |
Yes | 30 (71) | 24 (69) | 33 (75) | 25 (69) | Â |
No (recurrent) | 12 (29) | 11 (31) | 11 (25) | 11 (31) | Â |
Response to chemotherapy | Â | Â | Â | Â | 0.69 |
Responding (complete and partial) | 17 (40) | 13 (37) | 18 (41) | 15 (42) | Â |
Not responding (stable or progressive disease) | 25 (60) | 22 (63) | 26 (59) | 21 (58) | Â |